Microsoft Corp (MSFT)

[north40000]

An anomaly of good luck and bad luck I observed today:

1)  I bought 500 shares MSFT at $26/share on 12/30/2011. Those shares currently trade ~ $434/share. I have sold none over the years.
      Those shares are in a taxable account.


2)  I bought 200 shares AMRN at $7.68/share on 3/2/2011. Those shares currently trade ~ $0.60/share. I have accumulated a total of
      ~ 222,300 shares AMRN since that date at various prices, coupled with wash sales in IRA.. I am nearly break even in IRA, and have large
      short term and long term losses in a taxable account totaling ~ $182,000. 


Both MSFT and AMRN have post 4 pm earnings calls today, and Amarin has a 2 hour investor call scheduled in mid-November. I will be listening to the AMRN call. The FDA and EU along with other areas( e.g., China, Australia, New Zealand, Middle East, Canada) have given marketing approval for its Vascepa to treat, and reduce risk  of death from, various forms of cardiovascular disease( CVDs). One person dies every 38-40 seconds from heart disease in U.S., per CDC and/or WHO. The market is large, and I have confidence the market value of AMRN shares will eventually greatly exceed that of MSFT. Sarissa Capital, per its CEO Dr. Alex Denner, has bought a little less than 10% of Amarin shares in the belief that AMRN shares are undervalued. He and AMRN BOD and managers are looking for a buyout.